Switch to atovaquone and subsequent re‐challenge with trimethoprim‐sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|19|6|tid.12769-tid.12769

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.19, Iss.6, 2017-12, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trimethoprim-Sulfamethoxazole Exacerbates Posthypoxic Action Myoclonus in a Patient with Suspicion of Pneumocystis jiroveci Infection

By Jundt F.  

Infection, Vol. 32, Iss. 3, 2004-06 ,pp. : 176-178

Springer Publishing Company

Access to resources Recommend Favorite

The Increased Risk for Pneumocystis Pneumonia in Patients Receiving Rituximab-CHOP-14 Can Be Prevented by the Administration of Trimethoprim/Sulfamethoxazole: A Single-Center Experience

By  

Acta Haematologica, Vol. 127, Iss. 2, 2011-12 ,pp. : 110-114

Karger

Access to resources Recommend Favorite

Taking the challenge: A protocolized approach to optimize Pneumocystis pneumonia prophylaxis in renal transplant recipients

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 18, Iss. 2, 2018-02 ,pp. : 462-466

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Prolonged Treatment with Trimethoprim-Sulfamethoxazole on the Human Gut Flora

By Kofteridis Diamantis P.   Maraki Sofia   Mixaki Ioanna   Mantadakis Elpis   Samonis George  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 10, 2004-10 ,pp. : 771-772

Informa Healthcare

Access to resources Recommend Favorite

Trimethoprim–sulfamethoxazole (cotrimoxazole) desensitization in an HIV‐infected 5‐yr‐old girl

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 3, 2015-05 ,pp. : 287-289

John Wiley & Sons Inc

Access to resources Recommend Favorite